Alessa Therapeutics, Inc. — Form D
Alessa Therapeutics, Inc. of SAN CARLOS, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-05-01. The offering totals $31.6M, of which $25.4M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2025-05-01
- Form: D
- Accession: 0001771653-25-000005
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $31.6M
- Amount sold: $25.4M
- Remaining: $6.2M
- Minimum investment: $1
- Investors: 14
- Date of first sale: 2025-04-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-544914
Issuer
- Name: Alessa Therapeutics, Inc.
- CIK: 0001771653
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 930 BRITTAN AVENUE, SAN CARLOS, CA, 94070
- Phone: 650-223-5912
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Douglas Crawford | Director | San Francisco, CA |
| Cam Gallagher | Director | San Diego, CA |
| Richard Lim | Director | BOSTON, MA |
| Annie Mitsak | Director | Boston, MA |
| Pamela Munster | Director | San Carlos, CA |
| Steve Tregay | Director | San Carlos, CA |
| Zachary Collins | Executive Officer | Holland, MI |
| Cam Gallagher | Executive Officer | San Diego, CA |
| Peter Parker | Director | Boston, MA |
| John Maroney | Director | San Francisco, CA |
| John Maroney | Executive Officer | San Francisco, CA |
| Doug Crawford | Director | San Francisco, CA |
Other filings by this issuer (2)
More